Deiana Johnson
Wills Eye Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Deiana Johnson.
Ophthalmic Epidemiology | 2016
Lisa A Hark; Michael Waisbourd; Jonathan S. Myers; Jeffrey D. Henderer; John E. Crews; Jinan B. Saaddine; Jeanne Molineaux; Deiana Johnson; Harjeet Sembhi; Shayla Stratford; Ayman Suleiman; Laura T. Pizzi; George L. Spaeth; L. Jay Katz
ABSTRACT Purpose: The Wills Eye Glaucoma Research Center initiated a 2-year demonstration project to develop and implement a community-based intervention to improve detection and management of glaucoma in Philadelphia. Methods: The glaucoma detection examination consisted of: ocular, medical, and family history; visual acuity testing; corneal pachymetry; biomicroscopy of the anterior segment; intraocular pressure (IOP) measurement; gonioscopy; funduscopy; automated visual field testing; and fundus-color photography. Treatment included laser surgery and/or IOP-lowering medication. A cost analysis was conducted to understand resource requirements. Outcome measures included; prevalence of glaucoma-related pathology and other eye diseases among high-risk populations; the impact of educational workshops on level of knowledge about glaucoma (assessed by pre- and post-test evaluation); and patient satisfaction of the glaucoma detection examinations in the community (assessed by satisfaction survey). Treatment outcome measures were change in IOP at 4–6 weeks and 4–6 months following selective laser trabeculoplasty treatment, deepening of the anterior chamber angle following laser-peripheral iridotomy treatment, and rate of adherence to recommended follow-up examinations. Cost outcomes included total program costs, cost per case of glaucoma detected, and cost per case of ocular disease detected. Results: This project enrolled 1649 participants (African Americans aged 50+ years, adults 60+ years and individuals with a family history of glaucoma). A total of 1074 individuals attended a glaucoma educational workshop and 1508 scheduled glaucoma detection examination appointments in the community setting. Conclusions: The Philadelphia Glaucoma Detection and Treatment Project aimed to improve access and use of eye care and to provide a model for a targeted community-based glaucoma program.
Patient Education and Counseling | 2016
Deiana Johnson; Shayla Stratford; Andrew P. Shyu; Harjeet Sembhi; Jeanne Molineaux; Courtney Reamer; George L. Spaeth; Jonathan S. Myers; Lisa A Hark; L. Jay Katz; Michael Waisbourd
OBJECTIVES The purpose of this study was to investigate the impact of educational workshops, led by community health educators, on the level of knowledge, perceived risk of glaucoma, and rate of attendance in a subsequent glaucoma detection examination. METHODS Participants attended an educational workshop about glaucoma and completed an 8-question pre- and post-test to assess knowledge. A paired samples t-test assessed mean differences in composite pre- and post-test scores, correct responses for each question, and perceived risk of glaucoma after the workshop. RESULTS Seven hundred and seven (707) pre- and post-test surveys were completed. There was a significant increase in the level of knowledge about glaucoma as reflected in the pre- and post-test composite scores (M=3.86, SD=1.95 vs. M=4.97, SD=1.82, P<0.001). In the 5 largest community sites, 44% (n=221/480) of the participants who attended an educational workshop scheduled a glaucoma detection examination appointment and 76% (n=160/211) of these participants completed this eye examination in the community setting. CONCLUSIONS Educational workshops increased knowledge and awareness about glaucoma and were helpful in recruiting patients for community-based glaucoma detection examinations. PRACTICE IMPLICATIONS We recommend including educational workshops when conducting community-based outreach programs.
American Journal of Ophthalmology | 2017
Lisa A Hark; L. Jay Katz; Jonathan S. Myers; Michael Waisbourd; Deiana Johnson; Laura T. Pizzi; Benjamin E. Leiby; Scott J. Fudemberg; Anand V. Mantravadi; Jeffrey D. Henderer; Tingting Zhan; Jeanne Molineaux; Vance Doyle; Meskerem Divers; Christine Burns; Ann P. Murchison; Shae Reber; Arthur Resende; Thien Dan V. Bui; Jane Lee; John E. Crews; Jinan B. Saaddine; Paul P. Lee; Louis R. Pasquale; Julia A. Haller
PURPOSE To describe methodology and screening results from the Philadelphia Telemedicine Glaucoma Detection and Follow-up Study. DESIGN Screening program results for a prospective randomized clinical trial. METHODS Individuals were recruited who were African-American, Hispanic/Latino, or Asian over age 40 years; white individuals over age 65 years; and any ethnicity over age 40 years with a family history of glaucoma or diabetes. Primary care offices and Federally Qualified Health Centers were used for telemedicine (Visit 1). Two posterior fundus photographs and 1 anterior segment photograph were captured per eye in each participant, using a nonmydriatic, autofocus, hand-held fundus camera (Volk Optical, Mentor, Ohio, USA). Medical and ocular history, family history of glaucoma, visual acuity, and intraocular pressure measurements using the ICare rebound tonometer (ICare, Helsinki, Finland) were obtained. Images were read remotely by a trained retina reader and a glaucoma specialist. RESULTS From April 1, 2015, to February 6, 2017, 906 individuals consented and attended Visit 1. Of these, 553 participants were female (61.0%) and 550 were African-American (60.7%), with a mean age of 58.7 years. A total of 532 (58.7%) participants had diabetes, and 616 (68%) had a history of hypertension. During Visit 1, 356 (39.3%) participants were graded with a normal image. Using image data from the worse eye, 333 (36.8%) were abnormal and 155 (17.1%) were unreadable. A total of 258 (28.5%) had a suspicious nerve, 62 (6.8%) had ocular hypertension, 102 (11.3%) had diabetic retinopathy, and 68 (7.5%) had other retinal abnormalities. CONCLUSION An integrated telemedicine screening intervention in primary care offices and Federally Qualified Health Centers detected high rate of suspicious optic nerves, ocular hypertension, and retinal pathology.
Patient Preference and Adherence | 2016
Lisa A Hark; Deiana Johnson; Giuliana G. Berardi; Neal S. Patel; Lichuan Zeng; Yang Dai; Eileen L. Mayro; Michael Waisbourd; L. Jay Katz
Purpose Patients with glaucoma who do not keep their follow-up eye care appointments are at risk for developing more severe ocular disease. The primary aim of the current study was to evaluate whether the use of a patient navigator altered adherence to follow-up eye care appointments in community-versus office-based settings. Patients and methods Patients diagnosed with a glaucoma-related condition following a comprehensive eye examination at 43 community sites in Philadelphia, PA, USA, were enrolled in this prospective, randomized, controlled trial. Patients were randomized into three groups for a 1-year period: Group 1 (G1) received follow-up eye care in a community-based setting with assistance from a patient navigator; Group 2 (G2) received follow-up eye care in an office-based setting with assistance from a patient navigator; and Group 3 (G3) received follow-up eye care in an office-based setting without a patient navigator (usual care). Adherence rates were compared among these three groups using a chi-squared test at a significance level of 0.05. Results A total of 155 patients with glaucoma-related diagnoses were enrolled. The mean age (±standard deviation) was 71.2 (±10.0) years. Patients were predominantly female (65.8%, n=102/155) and African-American (71.6%, n=111/155). The mean (±standard deviation) number of follow-up visits during the 1-year study period was 1.3 (±1.3) for G1, 1.6 (±1.3) for G2, and 1.3 (±1.1) for G3 (P=0.48). Appointment adherence, defined as attendance of ≥1 follow-up visit, was 69.8% (n=37/53) for G1, 82.5% (n=47/57) for G2, and 73.3% (n=33/45) for G3, (P=0.28). Sub-analysis of adherence rates for patients who attended ≥2 follow-up visits were 91.3% (n=21/23) for G1, 74.3% (n=26/35) for G2, and 66.7% (n=18/27) for G3, (P=0.11). Conclusion Help from a patient navigator did not increase the likelihood of keeping ≥1 follow-up appointment in an office-based setting. Adherence rates for follow-up appointments reached close to 70% or above in a self-selected patient population.
Ophthalmology | 2016
Michael Waisbourd; Noelle L. Pruzan; Deiana Johnson; Angela Ugorets; John E. Crews; Jinan B. Saaddine; Jeffery D. Henderer; Lisa A Hark; L. Jay Katz
JAMA Ophthalmology | 2015
David Weiss; Robin J. Casten; Benjamin E. Leiby; Lisa A Hark; Ann P. Murchison; Deiana Johnson; Shayla Stratford; Jeffrey D. Henderer; Barry W. Rovner; Julia A. Haller
Investigative Ophthalmology & Visual Science | 2017
Kamran Rahmatnejad; Avrey Thau; Mathew E Biron; Eileen L. Mayro; Deiana Johnson; Tingting Zhan; Paul M. Gentile; Michael Waisbourd; Ann P. Murchison; L. Jay Katz; Scott S Fudemberg; Lisa A Hark
Investigative Ophthalmology & Visual Science | 2017
Joseph Okudolo; Lisa A Hark; L. Jay Katz; Megan Acito; Taylor DeVirgilio; Jeanne Molineaux; Mostafa Mazen; Jeffrey D. Henderer; Vance Doyle; Deiana Johnson; Meskerem Divers; Christine Burns; Julia A. Haller
Investigative Ophthalmology & Visual Science | 2017
Charles Edward Brodowski; Deiana Johnson; Saloni Sapru; Lisa A Hark; Jonathan S. Myers; Scott J. Fudemberg; Anand V. Mantravadi; Jeffrey D. Henderer; Vance Doyle; Jeanne Molineaux; Meskerem Divers; Christine Burns; Julia A. Haller; L. Jay Katz
Investigative Ophthalmology & Visual Science | 2017
Andrew Ines; Kamran Rahmatnejad; Lisa A Hark; L. Jay Katz; Michael Waisbourd; Jonathan S. Myers; Benjamin T. Leiby; Scott J. Fudemberg; Anand V. Mantravadi; Vance Doyle; Deiana Johnson; Jeanne Molineaux; Meskerem Divers; Christine Burns; Julia A. Haller